Oral versus intravenous antibiotic therapy for Staphylococcus aureus bacteremia or endocarditis: a systematic review and meta-analysis of randomized controlled trials

医学 随机对照试验 菌血症 荟萃分析 科克伦图书馆 心内膜炎 内科学 相对风险 不利影响 静脉治疗 置信区间 梅德林 重症监护医学 抗生素 法学 微生物学 生物 政治学
作者
Ahmad Mourad,Nnamdi Nwafo,Lesley A. Skalla,Thomas L Holland,Timothy C. Jenkins
出处
期刊:Clinical Infectious Diseases [Oxford University Press]
标识
DOI:10.1093/cid/ciae476
摘要

Abstract Background We conducted a systematic review of randomized controlled trials (RCTs) to generate more precise estimates of the efficacy and safety of oral versus intravenous antibiotic therapy for S. aureus bacteremia or endocarditis. Methods MEDLINE, EMBASE, the Cochrane Library, and Web of Science database were searched through February 21st, 2024. RCTs were included if they compared oral versus intravenous antibiotic therapy for S. aureus bacteremia or endocarditis, and appropriately reported outcomes for each group. Risk of bias was assessed using the revised Cochrane tool for assessing risk of bias in randomized trials. Heterogeneity between studies was evaluated with the Cochran’s Q-statistic and I2 test. Treatment effects were summarized with pooled risk ratios using a random effects model meta-analysis. (PROSPERO CRD42024481512) Results Only four RCTs met criteria for inclusion in meta-analysis. Among participants assessed for treatment failure, there was no difference between the oral and intravenous therapy groups (RR 0.99; 95% CI, 0.63–1.57; I2 = 0%). There was also no significant difference in adverse events between oral and intravenous therapy groups (RR 0.65; 95% CI, 0.07–5.94; I2 = 74%); however, the confidence interval is wide, and heterogeneity was high. Conclusions In this systematic review of RCTs comparing oral to intravenous antibiotic therapy for S. aureus bacteremia or endocarditis, few studies met eligibility criteria for inclusion. Meta-analysis of these studies suggests that transitioning from intravenous to oral therapy is likely effective in a subgroup of carefully selected patients. Additional randomized trials are necessary before transition to oral therapy can be routinely recommended.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
眼睛大忆梅完成签到,获得积分10
1秒前
晚云烟月应助啊锤你头采纳,获得10
1秒前
pasi发布了新的文献求助10
1秒前
everett_z完成签到,获得积分20
1秒前
BWZ发布了新的文献求助10
2秒前
天才c完成签到,获得积分10
2秒前
我去打球发布了新的文献求助10
2秒前
道明嗣完成签到 ,获得积分10
3秒前
哈哈呀完成签到 ,获得积分10
3秒前
科研通AI2S应助wxy采纳,获得10
3秒前
打打应助leiiiiiiii采纳,获得30
3秒前
3秒前
4秒前
5秒前
5秒前
chenchen完成签到,获得积分10
5秒前
眉姐姐的藕粉桂花糖糕完成签到 ,获得积分10
5秒前
ycool完成签到 ,获得积分10
5秒前
6秒前
maox1aoxin应助11111采纳,获得30
7秒前
7秒前
8秒前
老迟到的访文完成签到,获得积分10
8秒前
hanyu发布了新的文献求助10
8秒前
洋山芋完成签到,获得积分10
8秒前
KK完成签到,获得积分10
9秒前
ding应助xiao采纳,获得10
9秒前
岚婘完成签到,获得积分10
9秒前
raye发布了新的文献求助20
9秒前
从来都不会放弃zr完成签到,获得积分10
9秒前
noflatterer完成签到,获得积分10
9秒前
慕青应助TTXS采纳,获得10
9秒前
孟严青完成签到,获得积分10
9秒前
靓丽的熠彤完成签到,获得积分10
10秒前
10秒前
积极映梦完成签到,获得积分10
10秒前
人类后腿发布了新的文献求助10
10秒前
11秒前
11秒前
Hyh_完成签到 ,获得积分10
11秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3245017
求助须知:如何正确求助?哪些是违规求助? 2888685
关于积分的说明 8254872
捐赠科研通 2557077
什么是DOI,文献DOI怎么找? 1385764
科研通“疑难数据库(出版商)”最低求助积分说明 650225
邀请新用户注册赠送积分活动 626433